Stock Markets April 13, 2026 10:31 AM

Oracle, Revolution Medicines Lead Wide Swings in Market-Cap Movers on Monday

Mega-, large-, mid- and small-cap names moved sharply in both directions as company news and trial updates drove buying and selling

By Marcus Reed ORCL PLTR INTC GS RVMD
Oracle, Revolution Medicines Lead Wide Swings in Market-Cap Movers on Monday
ORCL PLTR INTC GS RVMD

Stocks across market-cap tiers experienced notable volatility on Monday. Oracle and several technology names advanced, while select consumer and optical-equipment firms fell. Biotechnology companies posted some of the largest gains and losses after trial results and regulatory developments influenced trader responses.

Key Points

  • Software and cloud-related companies saw notable gains after product and infrastructure announcements, boosting mega- and large-cap technology names.
  • Biotechnology firms produced some of the largest percentage swings, with positive clinical trial readouts lifting several mid- and large-cap biotech stocks while regulatory setbacks led to steep declines for others.
  • Analyst actions, including initiations and downgrades, contributed to directional moves in both technology and biotech names; consumer and optical-equipment firms recorded declines in the session.

Monday's session produced a range of market-cap-driven moves as company-specific announcements and clinical trial news pushed stocks higher and lower across sectors. Below is a categorized rundown of notable movers from mega-cap giants to small-cap names, including the reasons cited where available and the percentage moves recorded during the trading day.


Mega-Cap Movers (Market Cap: $200 billion USD or higher)

  • Oracle (ORCL); Oracle adds document review, inspection tools to Aconex platform +6.98%
  • Palantir Technologies Inc (PLTR) +3.51%
  • Intel Corp (INTC) +1.88%
  • Goldman Sachs Group (GS) -3.44%

Large-Cap Stock Movers (Market Cap: $10-$200 billion USD)

  • Revolution Medicines Inc (RVMD); Revolution Medicines reports positive phase 3 pancreatic cancer trial +35.1%
  • Credo Technology Holding (CRDO); Jefferies initiates Credo Technology stock with buy rating on AI growth +10.74%
  • CoreWeave (CRWV) +9.11%
  • Astera Labs (ALAB) +8.55%
  • Circle Internet Group Inc (CRCL) +8.27%
  • Cloudflare Inc (NET); Cloudflare expands agent cloud infrastructure for AI developers +7.77%
  • Albemarle (ALB) +7.18%
  • Workday Inc (WDAY) +6.06%
  • Applovin (APP) +5.14%
  • Lumentum Holdings Inc (LITE) -3.9%

Mid-Cap Stock Movers (Market Cap: $2-$10 billion USD)

  • Aeglea Bio Therapeutics Inc (SYRE); Spyre reports positive phase 2 data for ulcerative colitis drug +25.46%
  • Ideaya Biosciences Inc (IDYA); IDEAYA’s uveal melanoma drug combo meets trial goals +18.98%
  • SailPoint Tech (SAIL) +8.67%
  • Chenghe Acquisition II (PLBL) +8.77%
  • Cai International Inc (CAI) +7.53%
  • ADMA Biologics Inc (ADMA) +7.37%
  • Beam Inc. (BEAM) +6.05%
  • Tempus AI (TEM); Jefferies initiates Tempus AI stock with underperform rating +5.74%
  • Dutch Bros (BROS) -6.03%
  • Erasca (ERAS) -4.59%

Small-Cap Stock Movers (Market Cap: $300 million - $2 billion USD)

  • Replimune Group Inc (REPL); JPMorgan downgrades Replimune stock rating after second FDA rejection -67.75%
  • Allogene Therapeutics Inc (ALLO); Allogene reports interim data from lymphoma trial +46.14%
  • Lightwave Logic Inc (LWLG) +18.11%
  • Omnilit Acquisition (OPTX) +17.49%
  • Leggett & Platt (LEG); Somnigroup to acquire Leggett & Platt for $2.5 billion +13.51%
  • Biohaven Pharmaceutical Holding Co (BHVN) +10.03%
  • Aimei Health Tech (AFJK) -25.89%
  • SRM Entertainment (TRON) -8.43%
  • Mega Fortune Co Ltd (MGRT) -1.62%

Takeaway

Movements on Monday were driven by an array of catalysts cited by market participants in individual names: product additions and platform enhancements in the software space; analyst initiations and rating changes; clinical trial readouts and regulatory outcomes among biotech names; and corporate transactions for selected small-cap companies. The list above captures the most pronounced moves by market-cap band along with the specific items noted for certain issuers.

Note on coverage

The summary enumerates the prominent movers observed during the session and the company statements or analyst actions provided in association with those moves where the information was available.

Risks

  • Clinical trial outcomes and regulatory decisions can cause sudden, large moves in biotechnology stocks, affecting mid- and small-cap healthcare names.
  • Analyst ratings and coverage changes have the potential to materially influence share prices, particularly for growth-oriented technology and AI-related companies.
  • Company-specific developments, such as product updates or acquisitions, may drive volatility in their respective sectors and market-cap cohorts, adding uncertainty for investors trading those names.

More from Stock Markets

Helsinki Benchmark Closes at Record High as Telecoms and Tech Lead Gains Apr 13, 2026 Swedish equities slip as telecoms, healthcare and industrials lag - OMXS30 down 0.23% Apr 13, 2026 Emarketer Forecasts Meta to Overtake Google in Global Digital Ad Revenue by 2026 Apr 13, 2026 LVMH Says Iran War Knocked Sales in Gulf and Cut Into European Spending Apr 13, 2026 Options Traders Retract Some Premiums After U.S.-Iran Ceasefire, But Escalation Risk Persists Apr 13, 2026